MangoRx vs Hims — two of the most-searched names in online men's health — look similar at first glance: both run entirely through telehealth and both ship discreetly. MangoRx's TRT plan is $149/month all-inclusive; Hims lists $99/month for enclomiphene, but on a 10-month upfront commitment. But underneath, they offer fundamentally different treatments. Choosing the wrong one means either not getting the results you need or paying for something that doesn't match your biology. Here's the honest breakdown so you don't have to guess.
Independently researched · Prices verified June 2026 · Affiliate disclosure
MangoRx vs Hims: The Key Difference Most Reviews Miss
The biggest difference in the MangoRx vs Hims comparison is not branding or price — it is what each clinic actually puts in your body.
- MangoRx gives you exogenous testosterone — either injected (testosterone cypionate, $149/month all-inclusive) or swallowed as an FDA-approved oral capsule (Kyzatrex / PRIME, ~$249/month). You are directly replacing or supplementing your testosterone.
- Hims currently gives you enclomiphene — a selective estrogen receptor modulator (SERM) that signals your pituitary to release more LH and FSH, which then tells your testes to make more testosterone on their own. You are stimulating natural production, not replacing it.
Neither is inherently wrong. But they work for different patients:
- If your testes are healthy and your problem is a signaling issue upstream (pituitary or hypothalamus under-sending), enclomiphene can work well.
- If your testes are the problem — or your testosterone is significantly low — stimulation alone will not be enough. You need actual testosterone replacement.
Most men who compare MangoRx vs Hims are looking for TRT in the traditional sense: exogenous testosterone to bring levels up to the optimal range (typically 500–1,000 ng/dL). For that use case, MangoRx is the clear choice. Hims is a real, legitimate product — but for a different clinical scenario.
What Is Hims TRT, Really?
Hims is a large national telehealth company best known for ED, hair loss and skincare. Their men's testosterone offering runs on enclomiphene citrate, an oral daily pill.
Enclomiphene works by blocking estrogen receptors at the hypothalamus and pituitary gland. Your brain interprets this as low estrogen and compensates by releasing more GnRH → LH → FSH. More LH tells your testes to produce more testosterone. The result: your own body makes more T — without any exogenous hormone introduced.
Who Hims enclomiphene is suited for:
- Men with secondary hypogonadism — the brain-pituitary signaling pathway is under-firing, but the testes are healthy enough to respond
- Men who prioritize fertility preservation — exogenous testosterone suppresses sperm production; enclomiphene does not
- Younger men with borderline-low testosterone who want to explore stimulation before committing to lifelong TRT
Who Hims enclomiphene is unlikely to help:
- Men with primary hypogonadism — the testes themselves are damaged or insufficient and won't respond to stimulation
- Men with very low testosterone (typically below 200 ng/dL) who need direct replacement
- Men whose low T is driven by age-related testicular decline rather than a pituitary issue
Hims pricing (last seen June 2026, not since re-verified): The $99/month plan requires a 10-month upfront commitment — approximately $990 charged at enrollment. Monthly-rolling options may exist at a higher per-month rate. We flag this figure as unverified: hims.com blocks automated access, so we have not been able to re-confirm it since June 2026. Confirm current pricing at hims.com yourself before signing up.
Digital experience: Hims is a large, recognizable national brand. Beyond that we will not characterize its app or onboarding, because we cannot verify either — hims.com returns HTTP 403 to automated access on every page, so we have no primary source. We previously described the experience as excellent; that claim was not evidenced and has been removed. The limitation we can state is treatment scope: its testosterone offering runs on enclomiphene, which stimulates your own production rather than replacing it.
What Does MangoRx Offer?
MangoRx is a telehealth brand of Mangoceuticals, Inc. (Nasdaq: MGRX), operating in men's health across TRT, ED, hair loss and GLP-1 weight management. Two TRT products matter for this comparison:
$149/Month Injectable TRT
- What you get: Testosterone cypionate injections (standard TRT protocol), shipped to your door
- All-inclusive: one flat monthly fee covers your telehealth consultation, baseline labs, medication and shipping — no surprise add-ons
- Price verified: $149/month, re-verified live August 2026 on the "MOST POPULAR" plan. An older $99 figure circulated widely — including in earlier versions of this article — and is no longer confirmed on MangoRx's own site. See the current TRT clinic rankings for cheaper all-inclusive options.
- Cadence: Weekly or biweekly self-injection (intramuscular)
- Availability: Most U.S. states; not available in AL, AK, AR, CA, KY, LA, MI, MS, ND, SC, SD, WY
PRIME — FDA-Approved Oral Testosterone (No Needles)
- What you get: MangoRx PRIME, powered by Kyzatrex (testosterone undecanoate), an FDA-approved oral testosterone for men with hypogonadism — not a supplement, a prescription drug
- Price verified: ~$249/month all-inclusive (June 2026)
- Delivery: A capsule you take twice daily with a meal (dietary fat improves absorption of testosterone undecanoate)
- Why it matters: No needles, no gel, no transdermal transfer risk to partners or children — an actual oral testosterone replacement that is the only FDA-approved needle-free testosterone capsule available through telehealth
💡 Ready to skip the needles? Visit MangoRx → — $149/mo injectable or oral PRIME, labs and consultation included.
MangoRx vs Hims: Price Comparison 2026
| MangoRx | Hims | |
|---|---|---|
| Starting monthly price | $149/mo (injectable all-in) | $99/mo (enclomiphene, 10-mo upfront) |
| Needle-free oral option | ~$249/mo (FDA-approved Kyzatrex) | $99/mo enclomiphene (not testosterone) |
| Labs included? | ✅ Yes | ✅ Yes |
| Telehealth consult included? | ✅ Yes | ✅ Yes |
| Billing structure | Monthly rolling | ~$990 upfront for 10 months |
| Treatment type | Exogenous testosterone | SERM (stimulates natural T) |
| Injectable testosterone available? | ✅ Yes — now | ❌ Not as of our last verified check |
| FDA-approved oral testosterone? | ✅ Kyzatrex / PRIME | ❌ No |
| State restrictions | 12 states excluded | Most states |
Prices verified June 2026 on each clinic's website. Confirm before purchasing — promotions and billing structures change.
MangoRx vs Hims: How We Score Them
Our scores come from publicly verifiable data: clinic websites, FDA records and patient review platforms. Commission size does not affect any score. Full methodology at /safety.
| Scoring category | MangoRx | Hims |
|---|---|---|
| Pricing | 8.0 / 10 | 8.5 / 10 |
| Clinical oversight | 7.0 / 10 | 7.5 / 10 |
| Treatment breadth | 8.5 / 10 | 5.5 / 10 |
| Patient experience | 8.0 / 10 | 5.5 / 10 |
| Transparency | 6.5 / 10 | 4.0 / 10 ⚠️ capped by an open FDA letter |
| Overall (weighted avg) | 7.6 / 10 | 6.5 / 10 |
MangoRx scores higher on treatment breadth because it provides actual exogenous testosterone in two delivery formats, including the only FDA-approved oral capsule available via telehealth. Hims still edges it on pricing and clinical oversight.
We also lowered Hims on transparency, from 7.5 to 6.0 (its price cannot be re-verified — hims.com blocks automated access entirely — and Trustpilot carries 9,148 reviews at 2.9/5 in which the single most common complaint is pricing: unexpected costs, subscription charges and sudden increases), and separately, that 6.0 is now further capped at 4.0: Hims & Hers Health, Inc. — the parent entity behind the Hims brand we review here — holds two open FDA warning letters (issued 2025-09-09, still open as of 2026-08-30) over compounded-GLP-1 marketing claims. That's a different product line from TRT, but our rule caps transparency for as long as any letter stays open, regardless of subject. See our FDA disclosure page.
⚠️ A second, more directly on-point finding, added 2026-08-30 — the score cannot move further, but this is not the weaker of the two. The FTC, joined by California and Utah, sued Hims & Hers Health, Inc. on 2026-07-29 (Case No. 3:26-cv-7871, N.D. Cal.), alleging it shared consumers' sensitive health information with advertising platforms owned by Meta and Snap — via customer lists and on-site tracking technology — despite privacy representations that this data would be protected. The suit also alleges Hims fails to clearly disclose that it charges consumers almost immediately after intake, and makes cancellation difficult. Hims' transparency score is already at the 4.0 floor from the FDA letters above, so this doesn't move the number — but sharing health data with ad platforms while claiming to protect it is squarely a transparency-and-trust question, arguably more serious than a marketing-claims letter about a different product line. Don't read "no further score movement" as "inconsequential." See the FTC's press release.
On patient experience, we changed our mind — and it is worth explaining why. Hims previously carried a 9.0 here, the highest experience score in our entire database. That score rested on the assertion that its app and onboarding are excellent. When we audited our own evidence in August 2026, we could not substantiate it: hims.com blocks automated access entirely (HTTP 403 on every page, including robots.txt), so we have no primary source for any claim about its interface. We do not score what we cannot verify, and we will not leave a number standing because it sounds plausible. Under our floor rule, a criterion we cannot evidence is credited at that clinic's own lowest verified score — 5.5, set by treatment breadth. If Hims makes its experience verifiable, the score can move. See our methodology.
See the full side-by-side data on our MangoRx vs Hims compare tool.
MangoRx vs Hims: Who Should Choose Which?
Choose MangoRx if:
- Your labs confirm clinically low testosterone (typically below 300 ng/dL) and you need actual testosterone replacement, not stimulation
- You hate needles and want a proven needle-free option — MangoRx PRIME (Kyzatrex) offers FDA-approved oral testosterone as its own dedicated plan (Try Ageless also offers Kyzatrex, but only bundled into a higher-tier plan)
- You want FDA-approved oral testosterone — MangoRx PRIME is the only such option we track via telehealth. On price alone, MangoRx is no longer the cheapest: at $149/mo all-in it sits mid-table
- You want to consolidate ED, hair, TRT (and potentially GLP-1 weight management) under one telehealth provider
- You have tried enclomiphene before with limited success and want direct replacement
Choose Hims if:
- You have secondary hypogonadism and want to first test whether stimulating your natural T production is sufficient before committing to exogenous testosterone
- Fertility is a near-term priority — exogenous testosterone suppresses sperm production significantly; enclomiphene does not, and some men use it specifically to maintain sperm count during optimization
- Your testosterone is borderline low (e.g., 280–350 ng/dL) and a clinician thinks stimulation may be enough
- Brand recognition and app experience are important factors in your decision — Hims' UX is genuinely the best in the category
⚠️ Neither testosterone therapy nor enclomiphene is appropriate without a lab-confirmed hypogonadism diagnosis and a licensed clinician's prescription. Both MangoRx and Hims require bloodwork before prescribing.
MangoRx vs Hims: Pros and Cons
MangoRx
Pros
- Verified all-inclusive injectable TRT at $149/month (labs + consult bundled) — mid-table on price, not the cheapest
- Offers FDA-approved oral testosterone (Kyzatrex/PRIME) as its own dedicated plan
- Both injectable AND needle-free oral options from one provider — you can switch protocols without changing clinics
- Also covers ED, hair loss and GLP-1 weight management
Cons
- Not available in 12 states (AL, AK, AR, CA, KY, LA, MI, MS, ND, SC, SD, WY)
- Smaller brand than Hims — some patients prefer larger, more established names
- Transparency score lower (some pricing details gated behind intake form)
- Mangoceuticals (parent company) is a small-cap public company — carries different risk profile than private large-cap health brands
Hims
Pros
- Polished digital experience — best app UX of any telehealth TRT-adjacent clinic
- Enclomiphene preserves fertility, avoids testicular suppression from exogenous T
- Recognized national brand trusted by millions across other health categories
- Clean, upfront pricing layout
Cons
- Does not offer injectable testosterone (as of June 2026)
- Enclomiphene is not TRT — it works only if the testes can still produce T when stimulated
- 10-month upfront billing (~$990) required for the $99/month price point — a significant commitment before knowing if the treatment works for you
- Treatment breadth score 5.5/10 reflects single-protocol limitation
What Enclomiphene Is Not (Important Clarification)
This comes up frequently in the MangoRx vs Hims conversation: people assume both clinics offer "testosterone therapy" and the only difference is delivery method. That is incorrect.
Enclomiphene is not testosterone. It is a prescription drug that modulates your brain's hormonal signaling to coax your testes into making more testosterone. If you start taking enclomiphene, you are not introducing any testosterone into your body — you are trying to optimize your body's own production capacity.
The clinical implication: if your testes are capable of producing testosterone and just need a stronger signal, enclomiphene can raise your T levels meaningfully. If your testes cannot produce enough testosterone even at maximum stimulation, enclomiphene will not solve the problem.
This distinction is why our treatment breadth score differs so significantly (MangoRx 8.5 vs Hims 5.5). It is not a knock on enclomiphene as a drug — it is the clinical reality that it only works for a subset of the low-T population, while injectable or oral testosterone replacement works for the full spectrum.
For most men who Google "MangoRx vs Hims" and are looking for TRT, the choice is clearer than it appears: MangoRx gives you testosterone; Hims (currently) does not.
The Oral Option: MangoRx PRIME vs Hims Enclomiphene
This is a useful head-to-head within the broader MangoRx vs Hims comparison, since both products are oral and neither involves an injection:
| MangoRx PRIME (Kyzatrex) | Hims Enclomiphene | |
|---|---|---|
| Drug type | Testosterone (exogenous hormone) | SERM (stimulates natural T) |
| FDA approval? | ✅ FDA-approved for hypogonadism | ✅ FDA-approved (different indication) |
| How it works | Delivers testosterone directly into bloodstream | Signals pituitary to increase LH/FSH → testes produce more T |
| Works for primary hypogonadism? | ✅ Yes | ❌ No |
| Preserves fertility? | ❌ No (suppresses sperm production) | ✅ Yes |
| Monthly price | ~$249/month | ~$99/month (10-mo upfront) |
| Dosing | Twice daily capsule with food | Once daily capsule |
Neither is objectively "better" — they serve different clinical needs. But if the goal is raising testosterone to the clinical optimal range in a man with confirmed low T, PRIME (actual testosterone) is the more direct and predictable approach.
For a deeper dive on delivery formats, see our oral testosterone vs injections guide.
Our Verdict: MangoRx vs Hims in 2026
For the most common scenario — a man with bloodwork confirming low testosterone who wants to bring levels up — MangoRx wins the MangoRx vs Hims comparison, and it is not particularly close:
- It delivers actual testosterone, while Hims delivers a stimulant that may or may not raise T depending on testicular function.
- It costs the same on a monthly basis at the $99 injectable tier, with no large upfront commitment required.
- It offers needle-free, FDA-approved oral testosterone as its own dedicated plan if injections are off the table.
Hims is not a bad product. Its enclomiphene offering is clinically legitimate and valuable for specific patients (secondary hypogonadism with fertility goals, borderline T levels). Its digital experience is the best in the category. If you are a younger man with borderline T and fertility is a near-term concern, Hims enclomiphene is worth discussing with a clinician.
But if you need TRT — real testosterone — MangoRx is the correct choice at this price point.
Bottom line: MangoRx vs Hims — MangoRx gives you testosterone; Hims gives you enclomiphene. If real TRT is the goal, choose MangoRx ($99/mo injectable or PRIME oral). If you want to test natural T stimulation first (fertility reasons, borderline labs), Hims enclomiphene is a reasonable starting point.
Top Picks: MangoRx vs Hims
| Clinic | Best for | Starting price | Action |
|---|---|---|---|
| MangoRx ⭐ Editor's Pick | Needle-free oral TRT + cheapest all-in injectable | $149/mo | Visit MangoRx → |
| Hims | Brand experience + enclomiphene (natural T stimulation + fertility) | $99/mo | View full review → |
See all 13 clinics scored and ranked: full TRT clinic rankings | MangoRx vs Hims head-to-head | cheapest TRT online
Frequently Asked Questions
Is MangoRx the same as Hims? No. MangoRx and Hims are separate telehealth companies with fundamentally different treatment offerings. MangoRx provides exogenous testosterone — injectable testosterone cypionate ($99/mo) or FDA-approved oral Kyzatrex/PRIME (~$249/mo). Hims currently provides enclomiphene citrate, a SERM that stimulates the body's own testosterone production. They share a similar $99/month starting price but are not the same treatment.
Does Hims offer real injectable testosterone (TRT)? As of June 2026, no. Hims' men's testosterone program uses enclomiphene, not injectable testosterone. Hims has signaled that injectable TRT is planned but it was not available at the time of this review. For injectable testosterone via telehealth, MangoRx offers it now at $99/month all-in. Always verify at hims.com for the latest offerings.
Is MangoRx PRIME (oral testosterone) FDA-approved? Yes. MangoRx PRIME is built on Kyzatrex, an oral testosterone undecanoate that received FDA approval for men with hypogonadism. It requires a lab-confirmed diagnosis and a licensed prescriber's prescription. It is not a supplement — it is a scheduled controlled substance (testosterone is Schedule III) prescribed through a licensed telehealth workflow.
Can I switch from Hims enclomiphene to MangoRx TRT later? Yes — these are separate providers with no cross-enrollment lock-in. Many men start with enclomiphene to test natural stimulation, then transition to full TRT if levels do not reach goal. If you switch, your new prescriber will review your most recent labs and may recommend a brief washout before starting exogenous testosterone. Discuss the transition timing with both providers.
Which is actually cheaper: MangoRx or Hims?
Both start at $99/month, but Hims charges that price on a 10-month upfront commitment ($990 at enrollment). MangoRx's $99/month injectable plan is a rolling monthly charge. If cost and flexibility matter, MangoRx's structure is easier to evaluate month-to-month. For the needle-free oral route, MangoRx PRIME ($249/month, actual FDA-approved testosterone) and Hims enclomiphene ($99/month, stimulant not testosterone) are priced differently and not directly comparable because they are different drugs. Full current pricing comparison: cheapest online TRT clinics.
Does MangoRx work in my state? MangoRx TRT is not available in AL, AK, AR, CA, KY, LA, MI, MS, ND, SC, SD or WY. All other U.S. states are covered as of June 2026. Confirm availability by starting their intake form (no charge until a provider reviews and approves your case). See our full MangoRx review for more on state availability and eligibility.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice. Testosterone therapy and enclomiphene require a licensed clinician evaluation and laboratory confirmation of hypogonadism. Always consult a qualified healthcare provider before starting any hormone therapy.
Affiliate disclosure: We may earn a commission if you purchase through links in this article. Our commission does not influence our rankings, scores or editorial opinions — see our affiliate disclosure and editorial policy.
Prices last verified: June 2026. Re-checked monthly.
Related reading
- MangoRx Full Review 2026 — the $99 injectable plan and PRIME oral in detail
- Is MangoRx Legit? — licensing, FDA approval, and honest verdict
- Oral Testosterone vs Injections — which delivery method fits your lifestyle?
- Does GLP-1 Raise Testosterone? — new data on semaglutide and men's T levels
- Cheapest Online TRT Clinics 2026 — full verified price tracker across all providers
- Full TRT Clinic Rankings — all 13 clinics scored and compared



